8-K: Option Care Health Refinances Debt, Lowers Interest Costs

Option Care Health, Inc. has amended its First Lien Credit Agreement, refinancing existing term loans at a lower interest rate and extending maturity dates for both term and revolving credit facilities.

Summary

• Option Care Health, Inc. (OPCH) entered into a Fourth Amendment to its Amended and Restated First Lien Credit Agreement on September 22, 2025.
• The amendment refinances existing term loans with a new class of term loans totaling approximately $628,360,613.80.
• The new term loans bear interest at a lower rate of Term SOFR plus 1.75%, down from the previous Term SOFR plus 2.25%.
• The maturity date for the new term loans is seven years after the effective date of the amendment (September 22, 2025).
• The company incurred incremental term loans in the aggregate principal amount of $49,639,386.20, bearing the same interest rate and maturity as the refinanced term loans.
• The maturity date of the revolving credit commitments was extended to the fifth anniversary of the effective date of the amendment (September 22, 2025), subject to a springing maturity date 91 days prior to the Unsecured Notes maturity if any amount remains unpaid.
• Post-amendment, the principal amount of the First Lien Term Loan indebtedness under the Credit Agreement is approximately $678,000,000.
• The proceeds from the refinancing term loans will be used to repay existing term loans and cover transaction fees and expenses.
• The proceeds from the incremental term loans are designated for general corporate purposes, transaction fees and expenses, and other permitted uses.

Sentiment

Score: 8

Explanation: The filing indicates a positive financial restructuring, securing lower interest rates and extending debt maturities, which enhances the company's financial health and flexibility. While there are standard risks associated with debt, the overall impact of these changes is favorable for the company's capital structure.

Positives

• Achieved a lower interest rate on term loans (Term SOFR plus 1.75% from 2.25%), reducing borrowing costs.
• Extended the maturity date of term loans by seven years and revolving credit commitments by five years, improving liquidity and financial flexibility.
• Incurred additional incremental term loans for general corporate purposes, providing capital for strategic initiatives or operational needs.

Negatives

• A prepayment fee of 1.00% applies if Term B Loans or 2025 Amendment Term Loans are refinanced or amended to reduce All-In Yield within six months of the Amendment No. 4 Effective Date, excluding Transformative Acquisitions or change of control.

Risks

• The springing maturity date for revolving credit commitments, tied to the Unsecured Notes, could create refinancing pressure if Unsecured Notes remain unpaid 91 days prior to their maturity.
• Financial covenants (Total Net Leverage Ratio and Consolidated Fixed Charge Coverage Ratio) apply to Revolving Credit Lenders, and breaches could lead to an Event of Default for term loans after specific conditions are met by Revolving Credit Lenders.
• The company's ability to meet financial covenants is subject to fluctuations in Consolidated EBITDA and other financial components.

Future Outlook

The amendment provides Option Care Health with a more favorable debt structure, including lower interest costs and extended maturities, which should enhance financial flexibility for general corporate purposes and potential strategic initiatives. The company's ability to incur additional debt is tied to leverage ratios, allowing for future growth while maintaining financial discipline.

Industry Context

The refinancing and extension of credit facilities indicate a proactive approach to capital structure management, common among healthcare service providers seeking to optimize financing costs and ensure long-term liquidity in a dynamic market. Lower interest rates can improve profitability and competitiveness.

Comparison to Industry Standards

• The reduction in interest rate to Term SOFR plus 1.75% for first-lien term loans is competitive within the healthcare services sector for companies with strong credit profiles, potentially indicating favorable market conditions or improved company standing.
• The extension of debt maturities aligns with industry best practices for managing debt obligations and reducing near-term refinancing risk, providing stability for long-term strategic planning.
• The financial covenants (Total Net Leverage Ratio of 4.50:1.00 and Consolidated Fixed Charge Coverage Ratio of 1.50:1.00 for Revolving Credit Lenders) are within typical ranges for leveraged companies in the healthcare sector, balancing financial flexibility with creditor protection.

Stakeholder Impact

• Shareholders: Benefit from reduced interest expenses and improved financial stability, potentially leading to better profitability and valuation.
• Creditors (Lenders): The refinancing provides a new debt structure with extended maturities, while maintaining security interests in the collateral. The lower interest rate might be a slight negative for existing lenders if they don't participate in the new facility at the new rate, but overall debt stability is positive.
• Employees, Customers, Suppliers: Improved financial health and stability can indirectly benefit these stakeholders by ensuring continued operations and investment in the business.

Next Steps

• The company will continue to make quarterly principal repayments on the Term B Loans and 2025 Amendment Term Loans, commencing December 31, 2025.
• The company will need to comply with the financial covenants, including the Total Net Leverage Ratio and Consolidated Fixed Charge Coverage Ratio, for the benefit of Revolving Credit Lenders.
• The company may utilize the incremental debt capacity for general corporate purposes or strategic investments, subject to the specified leverage ratios.

Key Dates

Recommendation

The refinancing at a lower interest rate and the extension of debt maturities significantly improve Option Care Health's financial flexibility and reduce its cost of capital. This proactive debt management strengthens the balance sheet and provides a more stable foundation for future growth and operations. The ability to incur additional incremental debt, while adhering to reasonable leverage ratios, suggests a healthy capacity for strategic investments. These positive developments are likely to be viewed favorably by the market, supporting a 'buy' recommendation for long-term investors.

Keywords

Credit Agreement, Refinancing, Term Loans, Revolving Credit, Debt Restructuring, Interest Rate, Maturity Extension, Incremental Debt, SEC Filing, Financial Covenants, Corporate Finance